Cellular Neurothekeoma: Detailed Characterization in a Series of 133 Cases
Authors:
- Jason L. HornickJHJason L. Hornick
- Christopher D. M. FletcherCFChristopher D. M. Fletcher
- 1 March 2007
- journal article
- Published by Wolters Kluwer Health in American Journal of Surgical Pathology
- Vol. 31 (3) , 329-340
Abstract
Cellular neurothekeomas are distinctive benign cutaneous tumors of uncertain histogenesis. As relatively few cases have been reported, their clinical features and morphologic spectrum remain incompletely defined, and the significance of atypical histologic features is uncertain. This study examined the clinicopathologic and immunohistochemical features of 133 cellular neurothekeomas received between 1987 and 2003. There was a 1.8:1 female predominance, with a mean age of 25 years (84% or =5 per 10 high power fields. Most tumors showed mild cytologic atypia in the form of nuclear variability and small nucleoli; 33 (25%) contained notably pleomorphic cells. All tumors were reactive for NKI-C3, 110/123 (89%) expressed neuron-specific enolase, 73/127 (57%) showed at least focal staining for smooth muscle actin, and only 1 was focally desmin positive. All tumors were negative for S-100 protein. Follow-up ranged from 5 to 146 months (mean 44 mo). Ten tumors recurred locally (7 situated on the face), after a mean of 18 months; tumor had been marginally excised or had involved excision margins in all cases with available information. No other clinical or pathologic features correlated with recurrence. Cellular neurothekeomas have a predilection for the upper limbs and head and neck of pediatric and young adult females and rarely recur following incomplete excision. There is no good evidence that these lesions show nerve sheath differentiation and the nomenclature will likely change when the tumor cell lineage is better defined. Atypical histologic features (including pleomorphism, infiltration of subcutis, and a high mitotic rate) seem to have no clinical significance.Keywords
This publication has 26 references indexed in Scilit:
- Protein Gene Product 9.5 (PGP 9.5) Is Not a Specific Marker of Neural and Nerve Sheath Tumors: An Immunohistochemical Study of 95 Mesenchymal NeoplasmsLaboratory Investigation, 2003
- Analysis of Microphthalmia Transcription Factor Expression in Normal Tissues and Tumors, and Comparison of Its Expression With S-100 Protein, gp100, and Tyrosinase in Desmoplastic Malignant MelanomaAmerican Journal of Surgical Pathology, 2001
- Cellular Neurothekeoma with Possible Neuroendocrine DifferentiationThe Journal of Dermatology, 1999
- Atypical or Worrisome Features in Cellular NeurothekeomaAmerican Journal of Surgical Pathology, 1998
- Ultrastructural spectrum of cutaneous nerve sheath myxoma/cellular neurothekeomaJournal of Cutaneous Pathology, 1995
- Nerve sheath myxoma (neurothekeoma) of the skin: light microscopic and immunohistochemical reappraisal of the cellular variant*Journal of Cutaneous Pathology, 1993
- Cellular ‘neurothekeoma’: an epithelioid variant of pilar eiomyoma? Morphological and immunohistochemical analysis of a seriesHistopathology, 1992
- Studies on the cellular origin of neurothekeoma: Clinical, light microscopic, immunohistochemical, and ultrastructural observationsJournal of the American Academy of Dermatology, 1991
- Cellular Neurothekeoma A Distinctive Variant of Neurothekeoma Mimicking Nevomelanocytic TumorsAmerican Journal of Surgical Pathology, 1990
- Plexiform Fibrohistiocytic Tumor Presenting in Children and Young AdultsAmerican Journal of Surgical Pathology, 1988